A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day.

Objectives: To review published data on the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day which should be under consideration by the FDA in 2022 for sale over the counter in the US.

Study Design: A literature search in MEDLINE, EMBASE, and COCHRANE REVIEWS using specified search terms and adding related cross-references.

Results: We identified a total of thirteen relevant studies of women using norgestrel 75 µg/day.